From September 19th to 23rd, IVCC attended the International Congress for Tropical Medicine and Malaria (ICTMM) 2024 in Kuching, Malaysia. This congress, hosted by the International Federation for Tropical Medicine, highlighted global efforts and interdisciplinary research aimed at eliminating tropical diseases.
IVCC’s attendance was driven by its Indo-Pacific Initiative (funded by the Australian Government’s Dept for Foreign Affairs and Trade), particularly the NATNAT project, which seeks to tackle the growing challenge of malaria in Papua New Guinea (PNG). As malaria rises, insecticide-treated nets (ITNs) alone are insufficient to achieve elimination, making the evaluation and adoption of novel vector control tools (VCTs) essential.
NATNAT — which began in 2019 and was recently extended until 2027 — aims to strengthen PNG’s capacity to evaluate new VCTs, including building laboratory and field capabilities, conducting field evaluations, and investigating community acceptance of these tools. The project, which is led by Papua New Guinea Institute of Medical Research (PNGIMR), Burnet Institute and James Cook University, has also supported the National Malaria Control Program (NMCP) in establishing a national network for assessing and adopting new interventions, which is critical for bolstering malaria control in PNG.
At ICTMM, IVCC partners presented the results of a study on the efficacy of a metofluthrin spatial emanator (SumiOne™) in coastal villages of PNG. The talk, delivered by Michelle Katusele from the Papua New Guinea Institute of Medical Research (PNGIMR), showcased the promising impact of this novel VCT on malaria transmission.
By participating in ICTMM 2024, IVCC deepened its understanding of tropical disease challenges and strengthened partnerships, advancing efforts to bring new vector control solutions to the Indo-Pacific region.
IVCC at the third Global Health Security Conference 26th June 2024IVCC participated in the 2024 Global Health Security Conference in Sydney, from the 18th to the 21st of June.
The event brought together leaders, researchers, policy makers and representatives from private industry, international organisations and civil society. Discussions focused on strengthening health systems and explored ways to improve global responses to the most pressing health challenges.
IVCC was represented by Justin McBeath, CEO and Chris Larkin, Director of Operations & Communications. Together, they participated in a range of sessions, including a side event facilitated by the Australian Government Department of Foreign Affairs and Trade which brought together a range of Product Development Partnerships (e.g. IVCC, MMV, TB Alliance) to discuss areas of common challenge and opportunity with a particular focus on advancing Gender Equality & Social Inclusion (GEDSI). In addition, Justin McBeath was part of a panel for a session, hosted by GARDP (The Global Antibiotics Research and Development Partnership), on ‘Improving Access to Critical Health Products’.
IVCC was also an exhibitor at the conference, giving the opportunity for delegates to learn more about the scope our projects and initiatives.
Find out more about the third Global Health Security Conference online.